Literature DB >> 31882195

Overexpression of microRNA-375 and microRNA-122 promotes the differentiation of human induced pluripotent stem cells into hepatocyte-like cells.

Zahra Jaafarpour1, Masoud Soleimani2, Saman Hosseinkhani3, Bita Geramizadeh4, Parichehreh Yaghmaei5, Naser Mobarra6, Mohammad Hossein Karimi7.   

Abstract

MicroRNAs (miRNAs) are involved in the regulation of gene expression. In this study, we evaluated the use of overexpression of microRNA-375 (miR-375) and miR-122 in differentiating the Human Induced Pluripotent Stem Cells (hiPSCs) into functional hepatocyte-like cells (HLCs) without growth factors. We also compared the differentiation by miRNAs versus growth factors. HiPSCs were divided into two main groups: 1- HiPSCs were induced using lentiviral overexpression of miR-375 to differentiate into definitive endoderm (DE) cells in seven days. Then lentiviral overexpression of miR-122 was applied to differentiate DE cells into HLCs in additional 14 days. 2- HiPSCs were differentiated into HLCs using growth factors in 21 days. DE and hepatocyte markers were investigated by qRT-PCR, immunofluorescence, secretion analysis and LDL uptake assay. In the produced cells of both groups: the expression levels of DE markers (FOXA2 and SOX17) and hepatocyte markers (albumin, CK18, and HNF4a) in comparison with the undifferentiated hiPSCs increased significantly in seven and 21 days respectively. The albumin and urea secretion and LDL uptake were also detected. These results weren't significantly different between two groups. Therefore, we demonstrated that the over expression of miR-375 and then miR-122 could differentiate hiPSCs into functional HLCs without growth factors for developing cell-based therapies.
Copyright © 2019 International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Differentiation; Hepatocyte-like cell; Induced pluripotent stem cell; microRNA

Mesh:

Substances:

Year:  2019        PMID: 31882195     DOI: 10.1016/j.biologicals.2019.12.005

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  6 in total

Review 1.  MicroRNAs as Guardians of the Prostate: Those Who Stand before Cancer. What Do We Really Know about the Role of microRNAs in Prostate Biology?

Authors:  Thomas Andl; Kavya Ganapathy; Alexia Bossan; Ratna Chakrabarti
Journal:  Int J Mol Sci       Date:  2020-07-07       Impact factor: 5.923

2.  MicroRNA-22 enhances the differentiation of mouse induced pluripotent stem cells into alveolar epithelial type II cells.

Authors:  Fan Tao; Feng Wang; Weichen Zhang; Yaming Hao
Journal:  Eur J Histochem       Date:  2020-10-01       Impact factor: 3.188

3.  Hypoxia-Induced miR-210 Overexpression Promotes the Differentiation of Human-Induced Pluripotent Stem Cells to Hepatocyte-Like Cells on Random Nanofiber Poly-L-Lactic Acid/Poly (ε-Caprolactone) Scaffolds.

Authors:  Naser Mobarra; Sara Raji; Sara Najafi; Farzaneh Kamelan Kafi; Gordon A Ferns; Reza Pakzad
Journal:  Oxid Med Cell Longev       Date:  2021-11-22       Impact factor: 6.543

4.  Extracellular Vesicle-Encapsulated MicroRNA-375 from Bone Marrow-Derived Mesenchymal Stem Cells Inhibits Hepatocellular Carcinoma Progression through Regulating HOXB3-Mediated Wnt/β-Catenin Pathway.

Authors:  Zhaoxia Yu; Ju Liu; Qiqi Fan; Jun Yu; Xiaoting Ren; Xiaobin Wang
Journal:  Anal Cell Pathol (Amst)       Date:  2022-01-27       Impact factor: 2.916

5.  Beyond AOPs: A Mechanistic Evaluation of NAMs in DART Testing.

Authors:  Ramya Rajagopal; Maria T Baltazar; Paul L Carmichael; Matthew P Dent; Julia Head; Hequn Li; Iris Muller; Joe Reynolds; Kritika Sadh; Wendy Simpson; Sandrine Spriggs; Andrew White; Predrag Kukic
Journal:  Front Toxicol       Date:  2022-03-07

6.  Mir-122 upregulation and let-7f downregulation combination: The effects on hepatic differentiation of hiPSCs on the PCL-Gel-HA nanofibrous scaffold.

Authors:  Maliheh Parvanak; Zohreh Mostafavi-Pour; Masoud Soleimani; Amir Atashi; Ehsan Arefian; Elaheh Esmaeili
Journal:  J Cell Mol Med       Date:  2022-09-13       Impact factor: 5.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.